Virtu Financial LLC Vaxart, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.53 - $1.3 $7,063 - $17,326	13,328 New	13,328 $9,000
Q4 2023 Feb 26, 2024	BUY	$0.57 - $0.85 $24,534 - $36,586	43,043 New	43,043 $25,000
Q2 2023 Jul 27, 2023	BUY	$0.6 - $1.41 $88,927 - $208,980	148,213 New	148,213 $108,000
Q1 2021 May 19, 2021	SELL	$5.64 - $23.33 $1.01 Million - $4.16 Million	-178,488 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$3.5 - $7.98 $272,828 - $622,048	77,951 Added 77.53%	178,488 $1.02 Million
Q3 2020 Dec 11, 2020	BUY	$4.78 - $16.97 $480,566 - $1.71 Million	100,537 New	100,537 $669,000
Q4 2019 Feb 04, 2020	SELL	$0.28 - $0.39 $7,830 - $10,906	-27,966 Closed	0 $0
Q3 2019 Nov 20, 2019	SELL	$0.3 - $0.75 $2,110 - $5,277	-7,036 Reduced 20.1%	27,966 $10,000
Q2 2019 Aug 13, 2019	BUY	$0.63 - $2.04 $22,051 - $71,404	35,002 New	35,002 $23,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.